Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Inevitable reports are linking Bayer Animal Health to a buy-out from big players in the private equity world.
Animart has evolved its veterinary medication business into "an integrated animal health company" through a merger with fellow US firm Animal Profiling.
Dutch animal feed firm Royal De Heus has purchased a majority stake in Ukrainian company D-Mix, forming a joint venture.
Featured here are the animal health mergers and acquisitions covered by Animal Pharm during 2019.
MSD Animal Health has entered a deal to purchase Norwegian fish health specialist Scan Aqua for an undisclosed fee.
Plans to sell or spin-off Bayer Animal Health could come to light in April this year.
Evonik Industries has introduced its second venture capital fund with a volume of €150 million ($169 million).
US firm Archer Daniels Midland (ADM) has built an animal nutrition business with estimated sales of $3.5 billion after finalizing its purchase of France's Neovia.
Animal Pharm's most recent webinar highlighted the ongoing paucity of specialized investors in the animal health sector.
Heska will acquire an unnamed French business in the veterinary endoscopy equipment area.
Zoetis, Merck Animal Health and Biogénesis Bagó have all won Animal Pharm Awards in 2018 – adding to their accolades from previous years.
Italian companion animal health company Candioli aims to grow the European horizons of its latest acquisition.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.